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Abstract
A healthy heart exhibits fractal, i.e., long-range corre-
lated fluctuations in heart rate variability (HRV). It is re-
cently shown that fractal dynamics is also an intrinsic fea-
ture of human-induced pluripotent stem cell-derived car-
diomyocytes (hiPSC-CMs). In this study, we investigate
short- and long-range correlations in beat rate variabil-
ity (BRV) of hiPSC-CMs, obtained from a healthy subject
and symptomatic and asymptomatic long QT syndrome pa-
tients. It is shown that it is important to distinguish corre-
lation properties in short and long time scales, as the scal-
ing exponents are significantly different and also behave
differently in the acute exposure to pharmacological com-
pounds that modulate β1-adrenoreceptors and cardiac ion
channel generating delayed, outwardly rectifying K+ cur-
rent (IKs). While long-range scaling is sensitive to the drug
exposure, short-range scaling is barely affected.
1. Introduction
Self-similar patterns appear in many physiological time
series, such as R-R intervals, characterized by a power-
decaying relation with a non-integer scaling exponent.
Such properties are referred loosely as fractals, or having
long-range correlation.
In physiological systems, nonlinear complexity is often
related to the system’s autonomic regulation and robust-
ness against external perturbation. Many studies in the
past have confirmed the presence of fractal scaling in heart
rate variability (HRV) and its alteration due to aging [1]
and cardiac disorders, e.g., [2]. It was shown that isolated
heart cells, lacking any neural inputs, also exhibit power-
law scaling, suggesting that fractal-like beat rate fluctua-
tion is an intrinsic feature of heart cells [3].
Dynamics of spontaneously beating human heart cells,
or cardiomyocytes (CMs), has not been widely explored
until recently, when in vitro measurements of isolated hu-
man heart cells were made possible with newly developed
stem cell technologies. According to the revolutionary
scheme that led to the Nobel Prize in Medicine in 2012,
human-induced pluripotent stem cells (hiPSCs) can be ob-
tained from adult tissues such as skin and give rise to any
cell type in the body, including CMs [4].
In our previous work [5], we measured and analyzed the
beat-to-beat interval series of hiPSC-derived CMs (hiPSC-
CMs) and R-R interval of electrocardiogram (ECG), ob-
tained from a healthy individual and symptomatic and
asymptomatic long QT syndrome (LQTS, type 1) patients.
LQTS is a cardiac disease, characterized by prolonged QT
intervals in ECG. The inherited forms of LQTS are a result
of mutations in the cardiac ion channel coding genes [5].
We also tested the effect of pharmacological compounds,
applied directly to the cultured hiPSC-CMs. In this study,
we extend the work further to consider short- and long-
range correlation in different scale regimes, rather than
computing one global scaling exponent over all scales, and
assess the crossover behavior.
2. Data and Methods
2.1. hiPSC-CM preparation
The hiPSCs are generated as described in [6]. The
LQT1-specific hiPSCs are derived from LQTS patients’
skin fibroblasts carrying G589D missense mutation in
KCNQ1 [7, 8]. The skin biopsies are obtained from a
55-year-old female healthy individual, a symptomatic 41-
year-old female LQTS patient, and an asymptomatic 28-
year-old LQT-mutation carrier. Both symptomatic and
asymptomatic LQTS patients are on bisoprolol medica-
tion. The hiPSCs are cultured and differentiated into CMs
as described in [8]. In this study, 30-40 days old hiPSC-
CMs are used. The study is approved by the ethical com-
mittee of Pirkanmaa Hospital District (R08070).
2.2. hiPSC-CM and ECG data acquisition
Spontaneously beating hiPSC-CM clusters are mea-
sured with 6-well multielectrode array (MEA), as de-
scribed in [5]. After 30 minutes of baseline measurements,
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Bisoprolol (β-blocker), ML277 (IKs activator), and JNJ303
(IKs blocker) are applied. They are dissolved in either
dimethyl sulfoxide (DMSO) or H2O. Five minutes after
each addition of a drug, field potential data is recorded
for 30 minutes. The data is then analyzed by Cardiomy-
ocyte MEA Data Analysis (CardioMDA) [9] to produce
the hiPSC-CM cluster’s beat-to-beat interval series. Typi-
cal length of the hiPSC-CM data is about 1000-3000 beats.
ECGs of the individuals, whose hiPSC-CMs are studied,
are recorded using MARS-Holter. The ECG recordings
used here contain about 100000 beats.
2.3. Detrended fluctuation analysis
We apply detrended fluctuation analysis (DFA), origi-
nally developed in Ref. [10]. DFA is a reliable method to
quantify long-range correlation in a time series that may
be non-stationary.
In DFA, integrated time series (profile) is divided into
non-overlapping segments, from which a polynomial trend
is estimated by least-square fitting and subtracted, remov-
ing any monotonous trend. The fluctuation function is de-
fined by the root-mean-square of the variance of the resid-
uals of the profile. Since F (s) ∼ sα in the presence of
power-law scaling, plotting F (s) against s in log-log scale
and calculating the slope of the linear fit yields the scaling
exponent α. The algorithm used here is described more
thoroughly in Ref. [11].
The scaling exponent α describes the nature of the corre-
lation present in the data. The white noise with no correla-
tion and Brownian noise are characterized by α = 0.5 and
α = 1.5, respectively. 0.5 < α < 1.5 indicates long-range
correlation, i.e., fractal correlation, while α < 0.5 corre-
sponds to long-range anti-correlation [11]. It is important
to note here that time series may require more than one
scaling exponent to describe different behaviors at differ-
ent time scales. This crossover can be detected as change
in slope in the log-log plot of F (s) against s.
In order to determine the statistical significance in the
changes caused by the acute application of the drugs and
differences between the cell groups and short- and long-
range scaling exponents, paired sample t-test and indepen-
dent (unpaired) t-test are used, respectively. The levels of
significance are represented as asterisks: (*) p<0.05, (**)
p< 0.01, and (***) p<0.001.
3. Results and Discussion
3.1. Beat rate variability of hiPSC-CMs
Beat rate variability (BRV) of hiPSC-CMs , derived
from three individuals with different health conditions
are examined: healthy control, also called wild type
(WT), symptomatic LQTS patient, and asymptomatic
LQT-mutation carrier.
Applying DFA, we compute the scaling exponents α1
for time scales less than 16 beats, and α2 for scale longer
than 40 beats. They represent short-range and long-
range correlation respectively. In the extant literature on
crossover phenomena (e.g., [2]), α1 is usually defined by
scales less than 10 beats, but we choose 16 beats as our
threshold because crossover points occur after 16 beats in
most cases. DFA exponents are averaged over 38 data sets
of WT-CMs, 34 sets of symptomatic LQT-CMs, and 58
sets of asymptomatic LQT-CMs. The results are summa-
rized in Table 1.
Scaling behavior of the healthy control, also called wild
type (WT), and asymptomatic LQT-CMs are almost the
same. On the other hand, symptomatic LQT-CMs has sig-
nificantly smaller α1 (p<0.01, compared to asymptomatic
LQT-CMs), while the α2 is comparable to those of WT-
and asymptomatic LQT-CMs. The difference between
mean α1 and mean α2 is statistically significant in all cell
groups (p<0.001). The significant change in the scaling
behavior at short and long time scales indicates the exis-
tence of crossover. Thus, it is appropriate to describe the
BRV of the hiPSC-CMs with two and possibly more scal-
ing exponents.
Table 1. Average of DFA α1 and α2 values describing
short- and long-range correlation in BRV of hiPSC WT-
and LQT-CMs.
Cell group mean α1 mean α2
Wild type (healthy) 0.93± 0.19 1.10± 0.15
LQT (symptomatic) 0.84± 0.15 1.05± 0.23
LQT (asymptomatic) 0.94± 0.17 1.06± 0.20
Table 2. DFA α1 and α2 and their 95% confidence in-
tervals, calculated from R-R intervals of ECG, recorded
from the healthy control, symptomatic LQTS patient, and
asymptomatic LQT-mutation carrier.
ECG group α1 α2
Control (healthy) 1.12± 0.03 1.33± 0.03
LQT (symptomatic) 1.21± 0.01 1.08± 0.02
LQT (asymptomatic) 0.90± 0.01 1.00± 0.02
3.2. Comparison with ECG
R-R intervals, extracted from ECGs, are used to study
heart rate variability (HRV). Corresponding DFA results
are shown in Table 2 and illustrated in Fig. 1, presenting
short-range and long-range αs and their 95% confidence
intervals. The scaling properties are comparable between
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Figure 1. Fluctuation as a function of scale in log10 scales, computed by DFA algorithm, for the healthy control (WT) and
LQTS patients. α1 and α2 are calculated from least-square fitting on small scale (<14 beats) and large scale (>300 beats).
cellular and heart levels, especially for asymptomatic LQT-
CMs. Healthy control has higher α1 and α2 in ECG than
at the cellular level. The significantly reduced α1 of symp-
tomatic LQT-CMs is not observed in ECG data.
The findings confirm that hiPSC-CMs exhibit intrinsic
BRV with fractal scaling, and there are other internal and
external inputs affecting the fractal dynamics beyond the
cellular level: at the heart’s in situ level, sympathetic and
parasympathetic neural inputs regulate the heart rate, thus
affecting the fractal behavior.
3.3. Effects of pharmacological compounds
Three different pharmacological compounds are applied
to the hiPSC-CMs. Results are summarized in Fig. 2.
β-blocker Bisoprolol is a β1-adrenoreceptor selec-
tive β-blocker that is the standard treatment of choice for
LQTS patients. Acute application of bisoprolol leads to
a statistically significant increase in the long-range corre-
lation in all the cell groups. Above the therapeutic con-
centration (260nM), the effect attenuates or remains at the
same level for WT- and asymptomatic LQT-CMs. α2 in-
creases further towards Brownian noise (α = 1.5) for
symptomatic LQT-CMs, but not significantly.
IKs activator ML277 is an ion-channel activator,
known to shorten the action potential duration of CMs.
The application of ML277 to the hiPSC-CMs leads to a
significant increase in the long-range correlation in WT-
and asymptomatic LQT-CMs. In all the cell groups, higher
concentration does not increase α2 any further. There is no
significant change in short-range correlation.
IKs blocker JNJ303 is an effective and specific IKs
blocker. Though JNJ303 has the opposite effect on IKs
channel, its effect on the fractal scaling is similar to that
of ML277. Similar to other compound, application of
JNJ303 leads to significant increase inα2. The effect atten-
uates slightly or remains the same at higher concentration.
Again, no significant changes are observed in short-range
correlation.
WT- and asymptomatic LQT-CMs seem to be more sen-
sitive than symptomatic LQT-CMs to the drug exposures.
In summary, acute application of pharmacological com-
pounds that modulate β1-adrenoreceptors and cardiac ion
channel generating IKs alter the CM cluster’s fractal com-
plexity by increasing long-range correlation, but indepen-
dently of the applied dose. There is, however, no signif-
icant alteration in the short-range scaling due to the com-
pounds.
We have also performed vehicle control experiments, in
which CM clusters are measured without any drug expo-
sure, but with vehicle solutions, DMSO or H2O. We ob-
serve no statistically significant changes in α1 and α2,
when vehicle solutions are added every 30 minutes. There-
fore, significant changes in the scaling properties caused
by drug exposures reflect the intrinsic effects of the phar-
macological compounds themselves.
4. Conclusion
We have confirmed that fractal scaling properties are in-
deed intrinsic at the cellular level, also for LQT-CMs. In
particular, asymptomatic LQT-CMs show scaling behavior
very similar to that of healthy CMs, suggesting that the in-
trinsic mechanism contributing to fractality is not altered
by the presence of LQT-specific genetic mutation.
In this study, we have had a particular focus on two scal-
ing exponents to describe BRVs at short and long time
scales. The significant difference in the short and long
range αs indicates that it is appropriate to use two (or even
more) scaling exponents. Our results show that the effects
of drug exposure are different for the scaling properties
at short and long range: while short-range scaling is un-
altered by the modulation of β1-adrenoreceptors and car-
diac ion channels generating IKs, the long-range scaling is
sensitive to the drug exposure. Generally, the long-range
scaling exponents increase towards Brownian noise, inde-
pendently of the drug concentration.
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Figure 2. Change in average short-range correlation α1 and long-range correlation α2 as a function of drug concentration,
by cell groups and compounds. Significance levels are indicated by (*) p < 0.05, (**) p < 0.01, (***) p < 0.001.
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